Symbol: SUNPHARMA
Month: 2024-11
Start Price: ₹1847.27
End Price: ₹1770.23
12M Return: -4.17%
6M Return: -4.17%
3M Return: -4.17%
Volatility: 0.223
Sharpe Ratio: -2.569
Max Drawdown: -0.067
Peer Correlation (DRREDDY): 0.4471
Peer Correlation (DIVISLAB): 0.651
Peer Correlation (HINDUNILVR): 0.3152
Average Peer Correlation: 0.4711

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

SUNPHARMA's stock has been underperforming over the past year, with a 12-month return of -4.17%. The stock's volatility is moderate, with a standard deviation of 0.223. The Sharpe Ratio is negative, indicating that the stock's return is not justified by its risk. The maximum drawdown is relatively low, suggesting that the stock has not experienced a significant decline in value. SUNPHARMA has a moderate correlation with its peers, particularly with DIVISLAB, which may indicate similar market trends.

**Recommendation:**

Based on the analysis, I would suggest a **HOLD** position on SUNPHARMA. The stock's negative returns and Sharpe Ratio indicate that it may not be a good investment opportunity at present. However, the moderate volatility and low maximum drawdown suggest that the stock is not extremely risky. Additionally, the correlation with peers is not extremely high, which may indicate that SUNPHARMA has some unique characteristics that could potentially lead to a turnaround. It would be prudent to monitor the stock's performance and wait for a potential rebound or improvement in fundamentals before making a BUY or SELL decision.